Last Updated:
Searching
Create account to add to watchlist!

Summit Healthcare Acquisition Corp. - SMIH

  • Commons

    $9.70

    -0.21%

    SMIH Vol: 1.1K

  • Warrants

    $0.65

    +0.03%

    SMIHW Vol: 8.1K

  • Units

    $10.05

    +0.50%

    SMIHU Vol: 0.0

Average: 0
Rating Count: 0
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 193.8M
Average Volume: 4.1K
52W Range: $8.92 - $9.83
Weekly %: -0.21%
Monthly %: +0.00%
Inst Owners: 6

Info

Target: Searching
Days Since IPO: 172
Unit composition:
Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-half of one redeemable warrant
Trust Size: 20000000.0M

Management

Our executive officers, officers, directors and director nominees are as follows: Name Age Position Bo Tan 47 Chief Executive Officer, Co-Chief Investment Officer and Director Ken Poon 54 President, Co-Chief Investment Officer and Director Ian Stone 70 Independent Director Nominee Thomas Folinsbee 53 Independent Director Nominee Tao Bai 56 Independent Director Nominee Bo Tan, our Chief Executive Officer and Co-Chief Investment Officer, has over 20 years of extensive experience in the financial and pharmaceutical industries and was the President and Chief Financial Officer of 3S Bio from December 2016 to December 2019. During his tenure at 3S Bio, Mr. Tan led the privatization of 3SBio and its re-listing in Hong Kong in 2015, as well as the acquisition and integration of Sciprogen, Sirton (Italy), Wanma and CP Guojian, as well as investments in various landmark healthcare assets, including Ascentage, Sorrento and Refuge. From 2015 to 2019, Mr. Tan was voted the “Best CFO” for consecutive years in the Institutional Investor All-Asia Executive Team poll. Mr. Tan joined 3SBio in 2009 and 3SBio’s market capitalization increased approximately 10 times from 2009 to 2018. Before joining 3S Bio, Mr. Tan served as the executive director and a member of Investment Committee of Bohai Industrial Investment Fund Management Company, a PRC-based private equity firm, and presided over the investment in The Chengdu Commercial Bank, from April 2007 to September 2008. Prior to that, Mr. Tan served as a vice president in the equity research division of Lehman Brothers Asia Limited from March 2006 to March 2007 and as a senior analyst at Macquarie Securities Asia in Hong Kong from October 2004 to February 2006. Mr. Tan is widely acclaimed for his stellar track record of combining business operations and capital market prowess and has long-standing strategic relationships with major MNCs. Mr. Tan received his Bachelor’s degree in Economics from Renmin University of China in July 1994, Master’s degree in Economics from the University of Connecticut in December 1996 and a Master of International Management from Thunderbird School of Global Management in August 1998. Ken Poon, our President and Co-Chief Investment Officer, has nearly 30 years of capital markets experiences in Asia and is the founding partner of XCap Partners Limited, a boutique advisory firm in Hong Kong. Prior to founding XCap Partners Limited in 2019, Mr. Poon served as the Asia Pacific Head of Capital Markets Origination at Citigroup, running the Equity Capital Markets, Debt Capital Markets and Acquisition Finance businesses for all Asia ex-Japan. Prior to his tenure at Citigroup, Mr. Poon served as the Head of Asia Equity Capital Markets at Merrill Lynch from August 1998 to May 2004. Mr. Poon has led a series of landmark transactions globally, including Alibaba’s US$25 billion NYSE IPO, Luye Pharmaceutical’s US$878 million HKSE IPO, Samsung Biologic’s US$2 billion KOSE IPO, Chungwha Telecom Taiwan’s US$1.6 billion NYSE IPO and privatization, Melco’s US$1.3 billion Nasdaq IPO, TSMC’s US$2.0 billion registered ADR offering, China Mobile’s US$7.2 billion simultaneous placement of equity and convertibles, China Netcom’s US$1.2 billion dual listed NYSE and HKSE IPO, China CITIC Bank’s US$5.9 billion HKSE IPO, Longor Group’s US$1.0 billion HKSE IPO, CRCC’s US$2.3 billion HKSE IPO, Global Logistics Property US$3 billion SGX IPO, PetroChina’s US$2.4 billion Equity Placement, Sands China’s US$2.5 billion HKSE IPO and AIA’s US$20 billion HKSE IPO. He also led numerous billion-dollar bond offerings for companies such as Hutshison/Vodafone, Temasek/Singapore Telecom and Korea Telecom. Mr. Poon holds a Bachelor of Commerce degree in Finance from The University of British Columbia and a joint executive M.B.A from Northwestern University – Kellogg School of Management and Peking University – Guanghua School of Management. Ian Stone will serve as one of our directors as of the effective date of the registration statement. Mr. Stone joined Pontis Partners, a consulting business specializing in the telecom, internet and media industries, in 2001, 120 Table of Contents where he is currently a director. Through his position at Pontis Partners, Mr. Stone serves as a board member and advisor to a number of listed and private companies in the Asia and Middle East North Africa regions. In particular, Mr. Stone currently serves as an independent director of Tencent Holding Company (HKEX: 0700), one of Chinese largest online technology companies, and an independent director at Panther Media Group, a provider of direct-broadcast satellite, IPTV and OTT television services in the MENA region. From 2001 to 2014 Mr. Stone served in various positions at PCCW, a leading telecommunications and media company in Hong Kong, including as managing director of various business units. Thomas Folinsbee will serve as one of our directors as of the effective date of the registration statement. Mr. Folinsbee has over 25 years of experience as a financial and securities professional. Mr. Folinsbee has been the business development consultant of Shanghai Alebund Pharmaceuticals Ltd., a China-based pharmaceutical company, since 2019, where he is responsible for pharmaceutical inlicensing and outlicensing transactions. Prior to joining Alebund, Mr. Folinsbee was Director of Corporate Development of the strategic investment division of 3SBio Inc., a biotechnology company, from 2009 to 2019, focusing on sourcing business development opportunities in Canada, Australia, and Japan, including licensing, distribution, and M&A. Mr. Folinsbee joined 3SBio to manage its investor relations activities and was a member of the management group that delisted 3SBio from Nasdaq in May 2013 and relisted it on the Hong Kong Stock Exchange in June 2016. From 2017 to 2019, Mr. Folinsbee also served as independent director of Bison Capital Acquisition Corporation, a special purpose acquisition company that acquired Xynomic Pharmaceuticals Holdings, Inc. in 2019. Mr. Folinsbee continued to serve as independent director and was a member of the audit and compensation committees after the acquisition. From 2011 to 2016, Mr. Folinsbee also worked for Hisanaga Seisakusho Co. Ltd., a Japanese manufacturing company, where he helped launch Hisanaga’s sales platform in India and designed a business intelligence system to support a corporate turnaround. Before joining 3SBio Inc., Mr. Folinsbee also worked at Macquarie Equities, BNP Paribas and Optivest Systems Ltd. Mr. Folinsbee graduated in 1990 from McGill University with a Bachelor of Commerce degree concentrating in finance and international business (with distinction). Tao Bai will serve as one of our directors as of the effective date of the registration statement. Ms. Bai is a partner at the Beijing and Tianjin offices of JunHe Law Offices. Prior to joining JunHe Law Offices in 2002, Ms. Bai was a founding partner at Commerce & Finance Law offices from 1992 to 2002. Prior to that, Ms. Bai practiced with C&C Law Offices in Beijing from 1989 to 1992. Over the years, Ms. Bai has provided comprehensive legal services to many international clients, including multinational corporations and international organizations, as well as large Chinese enterprises and trade organizations, in the fields of IP protection, anti-dumping, M&A, project financing, IPOs, litigation, arbitration and administrative actions. Ms. Bai is a member of the All-China Bar Association, a Standing Director of Beijing Intellectual Property Protection Association, a member of the Chinese Society of International Law and the Inter-Pacific Bar Association, the Vice President of Beijing Bar Association and an arbitrator of the China International Economic and Trade Arbitration Commission, Shanghai International Economic and Trade Arbitration Commission and Hainan Arbitration Commission. Ms. Bai received the Outstanding and Lifetime Achievement for Asia Women in Business Law award from the Euromoney Legal Media Group in 2016. Ms. Bai received her LL.B. degree from Peking University Law School in 1985 and her J.D. degree from Cornell Law School in 1988. Number and Terms of Office of Officers and Directors Prior to the completion of an initial business combination, any vacancy on the board of directors may be filled by a nominee chosen by holders of a majority of our founder shares. In addition, prior to the completion of an initial business combination, holders of a majority of our founder shares may remove a member of the board of directors for any reason. Pursuant to an agreement to be entered into on or prior to the closing of this offering, our sponsor, upon and following the consummation of an initial business combination, will be entitled to nominate three individuals for election to our board of directors, as long as the sponsor holds any securities covered by the registration and shareholder rights agreement. 121 Table of Contents Our officers are appointed by the board of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors is authorized to appoint persons to the offices set forth in our amended and restated memorandum and articles of association as it deems appropriate. Our amended and restated memorandum and articles of association will provide that our officers may consist of one or more chairman of the board, chief executive officer, president, chief financial officer, vice presidents, secretary, treasurer and such other offices as may be determined by the board of directors. Director Independence Nasdaq listing standards require that a majority of our board of directors be independent. Our board of directors has determined that Ian Stone, Thomas Folinsbee and Tao Bai are “independent directors” as defined in the Nasdaq listing standards. Our independent directors will have regularly scheduled meetings at which only independent directors are present. Executive Officer and Director Compensation None of our executive officers or directors have received any cash compensation for services rendered to us. Commencing on the date that our securities are first listed on Nasdaq through the earlier of consummation of our initial business combination and our liquidation, we will reimburse an affiliate of our sponsor for office space, utilities, administrative services and remote support services provided to us in the amount of $10,000 per month. In addition, our sponsor, executive officers and directors, or their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made by us to our sponsor, executive officers or directors, or their respective affiliates. Any such payments prior to an initial business combination will be made using funds held outside the trust account. Other than quarterly audit committee review of such reimbursements, we do not expect to have any additional controls in place governing our reimbursement payments to our directors and executive officers for their out-of-pocket expenses incurred in connection with our activities on our behalf in connection with identifying and consummating an initial business combination. Other than these payments and reimbursements, no compensation of any kind, including finder’s and consulting fees, will be paid by the company to our sponsor, officers and directors, or their respective affiliates, for services rendered prior to completion of our initial business combination. After the completion of our initial business combination, members of our management team who remain with us may be paid consulting or management fees from the combined company. All of these fees will be fully disclosed to shareholders, to the extent then known, in the proxy solicitation materials or tender offer materials furnished to our shareholders in connection with a proposed business combination. We have not established any limit on the amount of such fees that may be paid by the combined company to our directors or members of management. It is unlikely the amount of such compensation will be known at the time of the proposed business combination, because the directors of the post-combination business will be responsible for determining executive officer and director compensation. Any compensation to be paid to our executive officers will be determined, or recommended to the board of directors for determination, either by a compensation committee constituted solely by independent directors or by a majority of the independent directors on our board of directors. We do not intend to take any action to ensure that members of our management team maintain their positions with us after the consummation of our initial business combination, although it is possible that some or all of our executive officers and directors may negotiate employment or consulting arrangements to remain with us after our initial business combination. The existence or terms of any such employment or consulting arrangements to retain their positions with us may influence our management’s motivation in identifying or selecting a target business but we do not believe that the ability of our management to remain with us after the consummation of our initial business combination will be a determining factor in our decision to proceed with 122 Table of Contents any potential business combination. We are not party to any agreements with our executive officers and directors that provide for benefits upon termination of employment. Committees of the Board of Directors Upon the effectiveness of the registration statement of which this prospectus forms a part, our board of directors will have three standing committees: an audit committee, a nominating committee and a compensation committee. Subject to phase-in rules and a limited exception, the rules of Nasdaq and Rule 10A-3 of the Exchange Act require that the audit committee of a listed company be comprised solely of independent directors. Subject to phase-in rules and a limited exception, the rules of Nasdaq require that the compensation committee and the nominating committee of a listed company be comprised solely of independent directors. Audit Committee Upon the effectiveness of the registration statement of which this prospectus forms a part, we will establish an audit committee of the board of directors. Ian Stone, Thomas Folinsbee and Tao Bai will serve as members of our audit committee. Our board of directors has determined that each of Ian Stone, Thomas Folinsbee and Tao Bai are independent under the Nasdaq listing standards and applicable SEC rules. Thomas Folinsbee will serve as the chairman of the audit committee. Under the Nasdaq listing standards and applicable SEC rules, all the directors on the audit committee must be independent. Each member of the audit committee is financially literate and our board of directors has determined that Thomas Folinsbee qualifies as an “audit committee financial expert” as defined in applicable SEC rules. The audit committee is responsible for: • meeting with our independent registered public accounting firm regarding, among other issues, audits, and the adequacy of our accounting and control systems; • monitoring the independence of the independent registered public accounting firm; • verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law; • inquiring and discussing with management our compliance with applicable laws and regulations; • pre-approving all audit services and permitted non-audit services to be performed by our independent registered public accounting firm, including the fees and terms of the services to be performed; • appointing or replacing the independent registered public accounting firm; • determining the compensation and oversight of the work of the independent registered public accounting firm (including resolution of disagreements between management and the independent registered public accounting firm regarding financial reporting) for the purpose of preparing or issuing an audit report or related work; • establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports which raise material issues regarding our financial statements or accounting policies; • monitoring compliance on a quarterly basis with the terms of this offering and, if any non-compliance is identified, immediately taking all action necessary to rectify such noncompliance or otherwise causing compliance with the terms of this offering; and • reviewing and approving all payments made to our existing shareholders, executive officers or directors and their respective affiliates. Any payments made to members of our audit committee will be reviewed and approved by our board of directors, with the interested director or directors abstaining from such review and approval. 123 Table of Contents Nominating Committee Upon the effectiveness of the registration statement of which this prospectus forms a part, we will establish a nominating committee of our board of directors. The members of our nominating committee will be Ian Stone, Thomas Folinsbee and Tao Bai, and Tao Bai will serve as chairman of the nominating committee. Under the Nasdaq listing standards, we are required to have a nominating committee composed entirely of independent directors. Our board of directors has determined that each of Ian Stone, Thomas Folinsbee and Tao Bai are independent. The nominating committee is responsible for overseeing the selection of persons to be nominated to serve on our board of directors. The nominating committee considers persons identified by its members, management, shareholders, investment bankers and others. Guidelines for Selecting Director Nominees The guidelines for selecting director nominees, which will be specified in a charter to be adopted by us, generally will provide that persons to be nominated: • should have demonstrated notable or significant achievements in business, education or public service; • should possess the requisite intelligence, education and experience to make a significant contribution to the board of directors and bring a range of skills, diverse perspectives and backgrounds to its deliberations; and • should have the highest ethical standards, a strong sense of professionalism and intense dedication to serving the interests of the shareholders. The nominating committee will consider a number of qualifications relating to management and leadership experience, background, integrity and professionalism in evaluating a person’s candidacy for membership on the board of directors. The nominating committee may require certain skills or attributes, such as financial or accounting experience, to meet specific board needs that arise from time to time and will also consider the overall experience and makeup of its members to obtain a broad and diverse mix of board members. The nominating committee does not distinguish among director nominees recommended by shareholders and other persons. Compensation Committee Upon the effectiveness of the registration statement of which this prospectus forms a part, we will establish a compensation committee of our board of directors. The members of our compensation committee will be Ian Stone, Thomas Folinsbee and Tao Ba

Holder Stats

1 0
% of Shares Held by All Insider 0.00%
% of Shares Held by Institutions 11.65%
% of Float Held by Institutions 11.65%
Number of Institutions Holding Shares 6

Mutual Fund Holders

Holder Shares Date Reported Value % Out
Saba Capital Income & Opportunities Fd 42915 2021-08-30 411554 0.21

Institutional Holders

Reporting Date Hedge Fund Shares Held Market Value % of Portfolio Quarterly Change in Shares Ownership in Company
2021-11-16 Schonfeld Strategic Advisors LLC 23,017 $220,000 0.0% 0 0.251%
2021-11-16 Whitebox Advisors LLC 250,000 $2,440,000 0.1% 0 2.729%
2021-11-16 CNH Partners LLC 131,000 $1,280,000 0.0% 0 1.430%
2021-11-15 Ancora Advisors LLC 24,800 $240,000 0.0% 0 0.271%
2021-11-15 Berkley W R Corp 36,958 $360,000 0.0% 0 0.403%
2021-11-15 Marshall Wace LLP 21,304 $210,000 0.0% 0 0.233%
2021-11-15 Glazer Capital LLC 15,183 $150,000 0.0% 0 0.166%
2021-11-15 Dark Forest Capital Management LP 60,316 $590,000 0.2% 0 0.658%
2021-11-12 Carlson Capital L P 30,000 $290,000 0.0% 0 0.328%
2021-11-10 Goldman Sachs Group Inc. 10,679 $100,000 0.0% 0 0.117%
2021-11-10 Segantii Capital Management Ltd 1,200,000 $11,700,000 0.4% 0 13.100%

SEC Filings

Form Type Form Description Filing Date Document Link
10-Q FORM 10-Q 2021-11-22 https://www.sec.gov/Archives/edgar/data/1839185/000119312521335901/d230417d10q.htm
8-K FORM 8-K 2021-11-22 https://www.sec.gov/Archives/edgar/data/1839185/000119312521335839/d403982d8k.htm
NT 10-Q FORM NT 10-Q 2021-11-15 https://www.sec.gov/Archives/edgar/data/1839185/000119312521328768/d197746dnt10q.htm
SC 13G 2021-08-26 https://www.sec.gov/Archives/edgar/data/1839185/000101143821000204/form_sc13g-summit.htm
10-Q FORM 10-Q 2021-08-16 https://www.sec.gov/Archives/edgar/data/1839185/000119312521247700/d148342d10q.htm
8-K FORM 8-K 2021-07-27 https://www.sec.gov/Archives/edgar/data/1839185/000095010321011195/dp155086_8k.htm
SC 13G 2021-06-29 https://www.sec.gov/Archives/edgar/data/1839185/000131924421000223/SMIH_SC13G.htm
8-K FORM 8-K 2021-06-17 https://www.sec.gov/Archives/edgar/data/1839185/000119312521193327/d148462d8k.htm
8-K FORM 8-K 2021-06-14 https://www.sec.gov/Archives/edgar/data/1839185/000119312521190073/d157526d8k.htm
424B4 424(B)(4) 2021-06-10 https://www.sec.gov/Archives/edgar/data/1839185/000119312521187812/d125103d424b4.htm
EFFECT 2021-06-08 https://www.sec.gov/Archives/edgar/data/1839185/999999999521002260/xslEFFECTX01/primary_doc.xml
3 FORM 3 SUBMISSION 2021-06-08 https://www.sec.gov/Archives/edgar/data/1839185/000089924321022661/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-06-08 https://www.sec.gov/Archives/edgar/data/1839185/000089924321022658/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-06-08 https://www.sec.gov/Archives/edgar/data/1839185/000089924321022657/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-06-08 https://www.sec.gov/Archives/edgar/data/1839185/000089924321022655/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-06-08 https://www.sec.gov/Archives/edgar/data/1839185/000089924321022652/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-06-08 https://www.sec.gov/Archives/edgar/data/1839185/000089924321022649/xslF345X02/doc3.xml
CERT 2021-06-08 https://www.sec.gov/Archives/edgar/data/1839185/000135445721000622/8A_Cert_SMIH.pdf
8-A12B FORM 8-A 2021-06-08 https://www.sec.gov/Archives/edgar/data/1839185/000119312521185093/d180433d8a12b.htm
CORRESP 2021-06-04 https://www.sec.gov/Archives/edgar/data/1839185/000119312521182436/filename1.htm
CORRESP 2021-06-04 https://www.sec.gov/Archives/edgar/data/1839185/000119312521182433/filename1.htm
CORRESP 2021-06-03 https://www.sec.gov/Archives/edgar/data/1839185/000119312521181078/filename1.htm
S-1/A AMENDMENT NO. 2 TO FORM S-1 2021-06-03 https://www.sec.gov/Archives/edgar/data/1839185/000119312521181075/d125103ds1a.htm
CORRESP 2021-06-03 https://www.sec.gov/Archives/edgar/data/1839185/000119312521180728/filename1.htm
CORRESP 2021-06-03 https://www.sec.gov/Archives/edgar/data/1839185/000119312521180724/filename1.htm
UPLOAD 2021-06-02 https://www.sec.gov/Archives/edgar/data/1839185/000000000021006826/filename1.pdf
CORRESP 2021-06-01 https://www.sec.gov/Archives/edgar/data/1839185/000119312521178076/filename1.htm
CORRESP 2021-06-01 https://www.sec.gov/Archives/edgar/data/1839185/000119312521178071/filename1.htm
CORRESP 2021-05-25 https://www.sec.gov/Archives/edgar/data/1839185/000119312521172477/filename1.htm
S-1/A AMENDMENT NO. 1 TO FORM S-1 2021-05-25 https://www.sec.gov/Archives/edgar/data/1839185/000119312521172470/d125103ds1a.htm
UPLOAD 2021-05-13 https://www.sec.gov/Archives/edgar/data/1839185/000000000021006074/filename1.pdf
CORRESP 2021-05-03 https://www.sec.gov/Archives/edgar/data/1839185/000119312521148014/filename1.htm
S-1 FORM S-1 2021-05-03 https://www.sec.gov/Archives/edgar/data/1839185/000119312521147994/d125103ds1.htm
UPLOAD 2021-03-03 https://www.sec.gov/Archives/edgar/data/1839185/000000000021002535/filename1.pdf
DRS 2021-02-03 https://www.sec.gov/Archives/edgar/data/1839185/000095012321000943/filename1.htm